Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.
Logothetis, C J
Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct 1988 - 1590-6 p. digital
Publication Type: Journal Article
0732-183X
10.1200/JCO.1988.6.10.1590 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Transitional Cell--drug therapy
Cisplatin--administration & dosage
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Follow-Up Studies
Humans
Lymphatic Metastasis
Neoplasm Invasiveness
Neoplasm Recurrence, Local
Prognosis
Urinary Bladder--surgery
Urinary Bladder Neoplasms--drug therapy
Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct 1988 - 1590-6 p. digital
Publication Type: Journal Article
0732-183X
10.1200/JCO.1988.6.10.1590 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Transitional Cell--drug therapy
Cisplatin--administration & dosage
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Follow-Up Studies
Humans
Lymphatic Metastasis
Neoplasm Invasiveness
Neoplasm Recurrence, Local
Prognosis
Urinary Bladder--surgery
Urinary Bladder Neoplasms--drug therapy